CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 300 enrolled
Drug / intervention
Paracetamol 1000 mg +2 moredrug
Likely dose
Paracetamol 1000 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01082081
NCT01082081Phase 4Completed
CompareCT.gov

A Study to Compare the Analgesic Efficacy of Two Different Paracetamol Doses as Measured by Post-operative Dental Pain Relief

GlaxoSmithKline·interventional·Posted Mar 8, 2010·Updated May 13, 2015

In Brief

A Phase 4 clinical trial evaluating Paracetamol 1000 mg, Paracetamol 500 mg, and 1 other intervention for Post-surgical Dental Pain. Completed, enrolled 300 participants across 2 sites.

Detailed Summary

GlaxoSmithKline will be conducting this trial to compare analgesics efficacy of paracetamol 1000mg vs 500mg . The post-surgical dental pain model will be used to evaluate the analgesic efficacy of paracetamol. Each subject will be enrolled in the study for up to six weeks. The duration of the entire study will be approximately 16 weeks. Each subject will have to come to the clinic for three visits (Screening, Treatment and Follow up visits).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPost-surgical Dental Pain
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedMar 8, 2010
Enrollment StartOct 1, 2009
Primary CompletionMar 1, 2010
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 16.3 years ago

Interventions

Paracetamol 1000 mgdrug

Paracetamol 1000 mg

Paracetamol 500 mgdrug

Paracetamol 500 mg

Placebodrug

Placebo